Does OBINUTUZUMAB Cause Hyperthermia? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hyperthermia have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.1% of all adverse event reports for OBINUTUZUMAB.
16
Reports of Hyperthermia with OBINUTUZUMAB
0.1%
of all OBINUTUZUMAB reports
2
Deaths
9
Hospitalizations
How Dangerous Is Hyperthermia From OBINUTUZUMAB?
Of the 16 reports, 2 (12.5%) resulted in death, 9 (56.3%) required hospitalization.
Is Hyperthermia Listed in the Official Label?
Yes, Hyperthermia is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Hyperthermia?
QUETIAPINE (265)
OLANZAPINE (210)
ACETAMINOPHEN (196)
OXALIPLATIN (195)
RISPERIDONE (166)
LAMOTRIGINE (156)
HALOPERIDOL (138)
CARBOPLATIN (129)
FLUOROURACIL (115)
SERTRALINE (109)
Which OBINUTUZUMAB Alternatives Have Lower Hyperthermia Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE